Cargando…

Evaluation of Prognostic Factors, including Duodenal P-Glycoprotein Expression, in Canine Chronic Enteropathy

SIMPLE SUMMARY: Canine chronic enteropathies are classified according to their response to diet, antibiotics, and immunosuppressant drugs, or to a lack of response to treatment. The aim of this study was to identify which factors, including P-glycoprotein activity (a membrane-bound protein involved...

Descripción completa

Detalles Bibliográficos
Autores principales: Pietra, Marco, Galiazzo, Giorgia, Bresciani, Francesca, Morini, Maria, Licarini, Sara, Turba, Maria Elena, Amaducci, Gianmaria, Bettini, Giuliano, Fracassi, Federico, Ostanello, Fabio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388466/
https://www.ncbi.nlm.nih.gov/pubmed/34438774
http://dx.doi.org/10.3390/ani11082315
_version_ 1783742649528745984
author Pietra, Marco
Galiazzo, Giorgia
Bresciani, Francesca
Morini, Maria
Licarini, Sara
Turba, Maria Elena
Amaducci, Gianmaria
Bettini, Giuliano
Fracassi, Federico
Ostanello, Fabio
author_facet Pietra, Marco
Galiazzo, Giorgia
Bresciani, Francesca
Morini, Maria
Licarini, Sara
Turba, Maria Elena
Amaducci, Gianmaria
Bettini, Giuliano
Fracassi, Federico
Ostanello, Fabio
author_sort Pietra, Marco
collection PubMed
description SIMPLE SUMMARY: Canine chronic enteropathies are classified according to their response to diet, antibiotics, and immunosuppressant drugs, or to a lack of response to treatment. The aim of this study was to identify which factors, including P-glycoprotein activity (a membrane-bound protein involved in multiple drug resistance), could be related to therapeutic failure. Ninety-two dogs were included in the study (73 with immunosuppressant-responsive enteropathy and 19 with non-responsive enteropathy). Factors significantly associated with an increased risk of belonging to the non-responsive group are previous treatment with glucocorticoids and hypoproteinemia. Moreover, using clonality testing, approximately one quarter of the non-responsive dogs showed a clonal response for T or B lymphocytes in the duodenal lymphocytes, although both histology and immunohistochemistry were not suggestive of lymphoma. In conclusion, additional studies are needed to investigate the underlying mechanisms that cause the non-responsive enteropathy, and whether a latent neoplastic disease could be related to the lack of response. ABSTRACT: The aim of this retrospective single-center study was to evaluate which factors, including expression of P-glycoprotein (P-gp), a membrane-bound protein involved in multiple drug resistance, could predict the response to treatment in canine immunosuppressant-responsive enteropathy (IRE). Dogs with IRE or non-responsive enteropathy (NRE) that were examined from 2005 to 2014 were included and were divided into two groups (IRE vs. NRE). Signalment, history, and clinical and laboratory findings were collected. P-glycoprotein immunohistochemistry was carried out on duodenal biopsies of both groups stored in our biobank, and immunophenotyping and molecular clonality were performed on the NRE samples. Ninety-two dogs were enrolled, 73 IRE (79.3%) and 19 NRE (20.7%), with a prevalence of pure breed (78.3% vs. 21.7%) and male dogs (p < 0.001). Factors associated with a worse prognosis were previous treatment with steroids (p = 0.033) and lower serum total protein concentration (p = 0.005). Clonality testing on the NRE duodenal biopsies showed 5/16 clonal responses, assuming a latent undiagnosed lymphoma as a possible cause of the NRE.
format Online
Article
Text
id pubmed-8388466
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-83884662021-08-27 Evaluation of Prognostic Factors, including Duodenal P-Glycoprotein Expression, in Canine Chronic Enteropathy Pietra, Marco Galiazzo, Giorgia Bresciani, Francesca Morini, Maria Licarini, Sara Turba, Maria Elena Amaducci, Gianmaria Bettini, Giuliano Fracassi, Federico Ostanello, Fabio Animals (Basel) Article SIMPLE SUMMARY: Canine chronic enteropathies are classified according to their response to diet, antibiotics, and immunosuppressant drugs, or to a lack of response to treatment. The aim of this study was to identify which factors, including P-glycoprotein activity (a membrane-bound protein involved in multiple drug resistance), could be related to therapeutic failure. Ninety-two dogs were included in the study (73 with immunosuppressant-responsive enteropathy and 19 with non-responsive enteropathy). Factors significantly associated with an increased risk of belonging to the non-responsive group are previous treatment with glucocorticoids and hypoproteinemia. Moreover, using clonality testing, approximately one quarter of the non-responsive dogs showed a clonal response for T or B lymphocytes in the duodenal lymphocytes, although both histology and immunohistochemistry were not suggestive of lymphoma. In conclusion, additional studies are needed to investigate the underlying mechanisms that cause the non-responsive enteropathy, and whether a latent neoplastic disease could be related to the lack of response. ABSTRACT: The aim of this retrospective single-center study was to evaluate which factors, including expression of P-glycoprotein (P-gp), a membrane-bound protein involved in multiple drug resistance, could predict the response to treatment in canine immunosuppressant-responsive enteropathy (IRE). Dogs with IRE or non-responsive enteropathy (NRE) that were examined from 2005 to 2014 were included and were divided into two groups (IRE vs. NRE). Signalment, history, and clinical and laboratory findings were collected. P-glycoprotein immunohistochemistry was carried out on duodenal biopsies of both groups stored in our biobank, and immunophenotyping and molecular clonality were performed on the NRE samples. Ninety-two dogs were enrolled, 73 IRE (79.3%) and 19 NRE (20.7%), with a prevalence of pure breed (78.3% vs. 21.7%) and male dogs (p < 0.001). Factors associated with a worse prognosis were previous treatment with steroids (p = 0.033) and lower serum total protein concentration (p = 0.005). Clonality testing on the NRE duodenal biopsies showed 5/16 clonal responses, assuming a latent undiagnosed lymphoma as a possible cause of the NRE. MDPI 2021-08-05 /pmc/articles/PMC8388466/ /pubmed/34438774 http://dx.doi.org/10.3390/ani11082315 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Pietra, Marco
Galiazzo, Giorgia
Bresciani, Francesca
Morini, Maria
Licarini, Sara
Turba, Maria Elena
Amaducci, Gianmaria
Bettini, Giuliano
Fracassi, Federico
Ostanello, Fabio
Evaluation of Prognostic Factors, including Duodenal P-Glycoprotein Expression, in Canine Chronic Enteropathy
title Evaluation of Prognostic Factors, including Duodenal P-Glycoprotein Expression, in Canine Chronic Enteropathy
title_full Evaluation of Prognostic Factors, including Duodenal P-Glycoprotein Expression, in Canine Chronic Enteropathy
title_fullStr Evaluation of Prognostic Factors, including Duodenal P-Glycoprotein Expression, in Canine Chronic Enteropathy
title_full_unstemmed Evaluation of Prognostic Factors, including Duodenal P-Glycoprotein Expression, in Canine Chronic Enteropathy
title_short Evaluation of Prognostic Factors, including Duodenal P-Glycoprotein Expression, in Canine Chronic Enteropathy
title_sort evaluation of prognostic factors, including duodenal p-glycoprotein expression, in canine chronic enteropathy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8388466/
https://www.ncbi.nlm.nih.gov/pubmed/34438774
http://dx.doi.org/10.3390/ani11082315
work_keys_str_mv AT pietramarco evaluationofprognosticfactorsincludingduodenalpglycoproteinexpressionincaninechronicenteropathy
AT galiazzogiorgia evaluationofprognosticfactorsincludingduodenalpglycoproteinexpressionincaninechronicenteropathy
AT brescianifrancesca evaluationofprognosticfactorsincludingduodenalpglycoproteinexpressionincaninechronicenteropathy
AT morinimaria evaluationofprognosticfactorsincludingduodenalpglycoproteinexpressionincaninechronicenteropathy
AT licarinisara evaluationofprognosticfactorsincludingduodenalpglycoproteinexpressionincaninechronicenteropathy
AT turbamariaelena evaluationofprognosticfactorsincludingduodenalpglycoproteinexpressionincaninechronicenteropathy
AT amaduccigianmaria evaluationofprognosticfactorsincludingduodenalpglycoproteinexpressionincaninechronicenteropathy
AT bettinigiuliano evaluationofprognosticfactorsincludingduodenalpglycoproteinexpressionincaninechronicenteropathy
AT fracassifederico evaluationofprognosticfactorsincludingduodenalpglycoproteinexpressionincaninechronicenteropathy
AT ostanellofabio evaluationofprognosticfactorsincludingduodenalpglycoproteinexpressionincaninechronicenteropathy